Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
19 March 2001Website:
http://www.harvardbioscience.comNext earnings report:
08 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 28 Jun 2024 20:19:32 GMTDividend
Analysts recommendations
Institutional Ownership
HBIO Latest News
HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14th Annual East Coast IDEAS Conference at the Jay Conference Center – Bryant Park in New York City on June 12, 2024.
Harvard Bioscience, Inc. (Nasdaq: HBIO) disclosed that Jim Green, Chairman and CEO, and Jennifer Cote, CFO, will take part in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, including a live fireside chat at 9:00-9:40 am ET. The Company will also hold individual meetings with investors during the Conference.
Harvard Bioscience, Inc. (Nasdaq: HBIO) is scheduled to release its financial results for the quarter ending on March 31, 2024 before the market opens on May 7, 2024. A conference call to discuss the results will take place at 8:00 a.m. Eastern Time.
HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at the upcoming Sidoti Small Cap Conference and KeyBanc Life Sciences & MedTech Conference, both to be held virtually in March 2024. Joining him will be Jennifer Cote, the Company's Chief Financial Officer.
HOLLISTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2023 before the market opens on March 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12th Annual Discovery One-on-One Investor Conference to be held Thursday December 7th, 2023 at the New York Athletic Club in New York City.
HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Southwest IDEAS Investor Conference on Thursday November 16, 2023 at The Statler in Dallas, Texas. Joining him will be Jennifer Cote, the company's Chief Financial Officer and Treasurer.
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q3 2023 Earnings Conference Call November 7, 2023 8:00 AM ET Company Participants Dave Sirois - Director, Corporate Accounting & SEC Reporting James Green - Chairman, President & Chief Executive Officer Jennifer Cote - Chief Financial Officer Conference Call Participants Bruce Jackson - The Benchmark Company Operator Thank you for standing by and welcome to the Harvard Biosciences Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded.
Harvard Bioscience (HBIO) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.05 per share a year ago.
HOLLISTON, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Sidoti August Virtual Investor Conference on August 16, 2023. Joining him will be Jennifer Cote, the company's Chief Financial Officer and Treasurer.
What type of business is Harvard Bioscience?
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
What sector is Harvard Bioscience in?
Harvard Bioscience is in the Healthcare sector
What industry is Harvard Bioscience in?
Harvard Bioscience is in the Medical Instruments & Supplies industry
What country is Harvard Bioscience from?
Harvard Bioscience is headquartered in United States
When did Harvard Bioscience go public?
Harvard Bioscience initial public offering (IPO) was on 19 March 2001
What is Harvard Bioscience website?
https://www.harvardbioscience.com
Is Harvard Bioscience in the S&P 500?
No, Harvard Bioscience is not included in the S&P 500 index
Is Harvard Bioscience in the NASDAQ 100?
No, Harvard Bioscience is not included in the NASDAQ 100 index
Is Harvard Bioscience in the Dow Jones?
No, Harvard Bioscience is not included in the Dow Jones index
When does Harvard Bioscience report earnings?
The next expected earnings date for Harvard Bioscience is 08 August 2024